Donaldson Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,508
Closed -$220K 240
2023
Q2
$220K Buy
+1,508
New +$205K 0.01% 220
2023
Q1
Sell
-1,686
Closed -$215K 235
2022
Q4
$215K Sell
1,686
-300
-15% -$34.8K 0.01% 220
2022
Q3
$208K Buy
+1,986
New +$218K 0.01% 214
2022
Q2
Sell
-1,586
Closed -$203K 256
2022
Q1
$203K Sell
1,586
-119
-7% -$14.3K 0.01% 249
2021
Q4
$210K Buy
1,705
+85
+5% +$11.1K 0.01% 254
2021
Q3
$230K Hold
1,620
0.01% 244
2021
Q2
$253K Sell
1,620
-52
-3% -$8.42K 0.01% 234
2021
Q1
$260K Buy
1,672
+52
+3% +$8.05K 0.01% 223
2020
Q4
$242K Sell
1,620
-3,896
-71% -$550K 0.01% 220
2020
Q3
$729K Buy
+5,516
New +$721K 0.05% 109
2020
Q1
Sell
-1,620
Closed -$235K 220
2019
Q4
$235K Buy
1,620
+36
+2% +$4.97K 0.02% 196
2019
Q3
$211K Buy
+1,584
New +$205K 0.02% 191
2018
Q4
Sell
-1,607
Closed -$205K 204
2018
Q3
$205K Buy
+1,607
New +$191K 0.02% 195

Other funds holding ZBH

Donaldson Capital Management's ZBH Position: Q3 2023 in Review

Donaldson Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,508 shares — an estimated $220K sold.

Donaldson Capital Management first reported a position in ZBH in Q3 2018 and held it in 13 quarters. The position peaked at $729K in Q3 2020. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • Donaldson Capital Management reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
  • Donaldson Capital Management sold 1,508 Zimmer Biomet shares in Q3 2023, an estimated $220K.
  • Donaldson Capital Management first reported a position in Zimmer Biomet in Q3 2018 and held it in 13 quarters.
  • Donaldson Capital Management's Zimmer Biomet position peaked at $729K in Q3 2020.
  • 1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Donaldson Capital Management's 13F filing for Q3 2023, filed 11 Oct 2023.